Lu Linlin, Doctor of Medicine,Professor,DoctoralSupervisor. She is a recipient of the National Natural Science Foundation of China for Excellent Young Scholars (2021), Guangdong Outstanding Youth Fund (2017), GuangdongYoungPearl River Scholar (2016), and Guangzhou Pearl River S&T Nova Program (2017). Her research focuses on target discovery and molecular mechanisms in individualized medication of traditional Chinesemateriamedica. Lu Linlin is currently affiliated with the International InstituteforTranslational Chinese Medicine at the School of Chinese Materia Medica, Guangzhou University of Chinese Medicine. In the past five years, she has published 85 articles in journals such asActa Pharmaceutica Sinica B,Pharmacological Research,Oncogene, andInternational Journal of Cancer, with a total impact factor of 313.834. As a principal investigator, she has led four projects funded by the National Natural Science Foundation and eight provincial and ministerial projects. Additionally, Lu Linlin has obtained 11 invention patents. She serves as an editorial board member for journals likePharmacological Research,Frontiers in Pharmacology, andPhytomedicine.